Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2017

24.08.2016 | Maternal-Fetal Medicine

Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas

verfasst von: I. Dedes, L. Schäffer, R. Zimmermann, T. Burkhardt, C. Haslinger

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Aim

To evaluate the outcome of a cesarean myomectomy (CM) versus a cesarean delivery (CD) alone in women with uterine myomas and the risk factors for adverse outcomes.

Methods

A retrospective cohort study of all women undergoing CDs with uterine leiomyomatas and singleton pregnancies was performed. Patients with known risk factors for hemorrhage were excluded. Measured adverse outcome parameters included estimated blood loss, drop in hemoglobin levels (pre/postoperatively), operation time, and the use of additional uterotonics. Outcome parameters of women with CM were compared to women with CD alone. Possible risk factors for adverse outcomes were analyzed in a multivariate regression analysis. Evaluated risk factors for CM were according to localization and type of myomatas, the myoma size, BMI ≥30 kg/m2, age ≥40 years, fetal weight ≥4 kg, repeat CD, and unplanned CD in the first stage of labor. The influence of localization and myoma type were further analyzed in a subgroup analysis.

Results

Of the 162 women with uterine myomatas during CD, 48 underwent CM and were analyzed. Overall, CM was not associated with adverse outcomes. Independent of a concomitant myomectomy, a large myoma size of ≥5 cm was associated with an increased blood loss of ≥500 ml (adj. OR 2.7 CI 95 % 1.2–6.2, p = 0.02), and women ≥40 years of age had a significant postoperative drop in hemoglobin (adj. OR 2.4 CI 95 % 1.0–5.4, p = 0.04). In the univariate subgroup analysis, CM of multiple myomatas was associated with an increased blood loss and an increased operation time compared to women with multiple myomatas and CD alone. Prolonged operation times were also observed in women with pedunculated and subserosal myomatas with concomitant myomectomy. There were no cases of hysterectomy or blood transfusions.

Conclusion

CM performed by an experienced obstetrician can be safe in selected patients who are without additional preexisting risk factors. Risk factors that are associated with increased blood loss in women with uterine leiomyomatas include a larger size of the leiomyoma (≥5 cm) and a maternal age of ≥40 years.
Literatur
1.
Zurück zum Zitat Al-Zirqi I, Vangen S, Forsen L et al (2008) Prevalence and risk factors of severe obstetric haemorrhage. BJOG 115:1265–1272CrossRefPubMed Al-Zirqi I, Vangen S, Forsen L et al (2008) Prevalence and risk factors of severe obstetric haemorrhage. BJOG 115:1265–1272CrossRefPubMed
2.
Zurück zum Zitat Blomberg M (2011) Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol 118:561–568CrossRefPubMed Blomberg M (2011) Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol 118:561–568CrossRefPubMed
3.
Zurück zum Zitat Cook H, Ezzati M, Segars JH et al (2010) The impact of uterine leiomyomas on reproductive outcomes. Min Ginecol 62:225–236 Cook H, Ezzati M, Segars JH et al (2010) The impact of uterine leiomyomas on reproductive outcomes. Min Ginecol 62:225–236
4.
Zurück zum Zitat Declercq E, Young R, Cabral H et al (2011) Is a rising cesarean delivery rate inevitable? Trends in industrialized countries, 1987–2007. Birth 38:99–104CrossRefPubMed Declercq E, Young R, Cabral H et al (2011) Is a rising cesarean delivery rate inevitable? Trends in industrialized countries, 1987–2007. Birth 38:99–104CrossRefPubMed
5.
6.
Zurück zum Zitat Hill M, Reed KL, Cohen WR (2014) Oxytocin utilization for labor induction in obese and lean women. J Perinat Med 43(6):703–706 Hill M, Reed KL, Cohen WR (2014) Oxytocin utilization for labor induction in obese and lean women. J Perinat Med 43(6):703–706
7.
Zurück zum Zitat Klatsky PC, Tran ND, Caughey AB et al (2008) Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 198:357–366CrossRefPubMed Klatsky PC, Tran ND, Caughey AB et al (2008) Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 198:357–366CrossRefPubMed
8.
9.
Zurück zum Zitat Lam SJ, Best S, Kumar S (2014) The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol 211(395):e391–e395 Lam SJ, Best S, Kumar S (2014) The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol 211(395):e391–e395
10.
Zurück zum Zitat Lao TT, Sahota DS, Cheng YK et al (2014) Advanced maternal age and postpartum hemorrhage—risk factor or red herring? J Matern Fetal Neonatal Med 27:243–246CrossRefPubMed Lao TT, Sahota DS, Cheng YK et al (2014) Advanced maternal age and postpartum hemorrhage—risk factor or red herring? J Matern Fetal Neonatal Med 27:243–246CrossRefPubMed
11.
Zurück zum Zitat Pergialiotis V, Vlachos DG, Rodolakis A et al (2014) First versus second stage C/S maternal and neonatal morbidity: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 175:15–24CrossRefPubMed Pergialiotis V, Vlachos DG, Rodolakis A et al (2014) First versus second stage C/S maternal and neonatal morbidity: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 175:15–24CrossRefPubMed
12.
Zurück zum Zitat Song D, Zhang W, Chames MC et al (2013) Myomectomy during cesarean delivery. Int J Gynaecol Obstet 121:208–213CrossRefPubMed Song D, Zhang W, Chames MC et al (2013) Myomectomy during cesarean delivery. Int J Gynaecol Obstet 121:208–213CrossRefPubMed
13.
Zurück zum Zitat Szamatowicz J, Laudanski T, Bulkszas B et al (1997) Fibromyomas and uterine contractions. Acta Obstet Gynecol Scand 76:973–976CrossRefPubMed Szamatowicz J, Laudanski T, Bulkszas B et al (1997) Fibromyomas and uterine contractions. Acta Obstet Gynecol Scand 76:973–976CrossRefPubMed
14.
Zurück zum Zitat Tinelli A, Malvasi A, Mynbaev OA et al (2014) The surgical outcome of intracapsular cesarean myomectomy. A match control study. J Matern Fetal Neonatal Med 27:66–71CrossRefPubMed Tinelli A, Malvasi A, Mynbaev OA et al (2014) The surgical outcome of intracapsular cesarean myomectomy. A match control study. J Matern Fetal Neonatal Med 27:66–71CrossRefPubMed
15.
Zurück zum Zitat Vitale SG, Padula F, Gulino FA (2015) Management of uterine fibroids in pregnancy: recent trends. Curr Opin Obstet Gynecol 27:432–437CrossRefPubMed Vitale SG, Padula F, Gulino FA (2015) Management of uterine fibroids in pregnancy: recent trends. Curr Opin Obstet Gynecol 27:432–437CrossRefPubMed
16.
Zurück zum Zitat Vitale SG, Tropea A, Rossetti D et al (2013) Management of uterine leiomyomas in pregnancy: review of literature. Updates Surg 65:179–182CrossRefPubMed Vitale SG, Tropea A, Rossetti D et al (2013) Management of uterine leiomyomas in pregnancy: review of literature. Updates Surg 65:179–182CrossRefPubMed
Metadaten
Titel
Outcome and risk factors of cesarean delivery with and without cesarean myomectomy in women with uterine myomatas
verfasst von
I. Dedes
L. Schäffer
R. Zimmermann
T. Burkhardt
C. Haslinger
Publikationsdatum
24.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4177-8

Weitere Artikel der Ausgabe 1/2017

Archives of Gynecology and Obstetrics 1/2017 Zur Ausgabe

Correspondence

Answer to the editor

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.